{"id":470862,"date":"2023-08-28T23:19:47","date_gmt":"2023-08-29T06:19:47","guid":{"rendered":"https:\/\/nai500.com\/?p=470862"},"modified":"2023-08-28T23:19:47","modified_gmt":"2023-08-29T06:19:47","slug":"%e5%8d%8e%e5%b0%94%e8%a1%97-%e5%b0%8f%e5%9e%8b-%e7%94%9f%e7%89%a9%e7%a7%91%e6%8a%80%e8%82%a1%e7%a5%a8-%e6%9a%b4%e6%b6%a8","status":"publish","type":"post","link":"https:\/\/nai500.com\/zh-hans\/blog\/2023\/08\/%e5%8d%8e%e5%b0%94%e8%a1%97-%e5%b0%8f%e5%9e%8b-%e7%94%9f%e7%89%a9%e7%a7%91%e6%8a%80%e8%82%a1%e7%a5%a8-%e6%9a%b4%e6%b6%a8\/","title":{"rendered":"\u534e\u5c14\u8857\uff1a\u8fd9\u53ea\u5c0f\u578b\u7684\u751f\u7269\u79d1\u6280\u80a1\u7968\u6216\u5373\u5c06\u8fce\u6765\u66b4\u6da8"},"content":{"rendered":"<h2>FDA\u7684\u5ba1\u6279\u51b3\u5b9a\u6216\u6210\u4e3a\u8fd9\u53ea\u751f\u7269\u79d1\u6280\u516c\u53f8\u751f\u547d\u5468\u671f\u7684\u4e00\u4e2a\u62d0\u70b9<\/h2>\n<p>\u5bf9\u4e8e\u6210\u957f\u6295\u8d44\u8005\u6765\u8bf4\uff0c\u57fa\u56e0\u7597\u6cd5\u9f99\u5934\u516c\u53f8<a href=\"https:\/\/nai500.com\/zh-hans\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%af%a2\/?qm_symbol=BLUE\">Bluebird bio Inc\uff08NASDAQ:BLUE\uff09<\/a>\u662f\u4e00\u53ea\u5f88\u597d\u7684\u9009\u80a1\u3002\u8be5\u516c\u53f8\u7684\u4e24\u6b3e\u57fa\u56e0\u7597\u6cd5Zynteglo\uff08betibeglogene autotemcel\uff09\u548cSkysona\uff08elivaldogene autotemcel\uff09\u5df2\u83b7\u7f8e\u56fd\u98df\u54c1\u836f\u54c1\u76d1\u7763\u7ba1\u7406\u5c40\uff08FDA\uff09\u7684\u6279\u51c6\u3002Zynteglo\u662f\u7b2c\u4e00\u6b3e\u6cbb\u7597\u03b2-\u5730\u4e2d\u6d77\u8d2b\u8840\u7684\u57fa\u56e0\u7597\u6cd5\uff0c\u800cSkysona\u7528\u4e8e\u6cbb\u7597\u5e74\u9f84\u57284-17\u5c81\uff0c\u60a3\u6709\u8111\u80be\u4e0a\u817a\u8111\u767d\u8d28\u8425\u517b\u4e0d\u826f\uff08CALD\uff09\u7684\u7537\u5b69\u3002<\/p>\n<p>\u4e0d\u8fc7\uff0c\u534e\u5c14\u8857\u5bf9\u4e8e\u8fd9\u4e24\u79cd\u57fa\u56e0\u7597\u6cd5\u7684\u5546\u4e1a\u524d\u666f\u5e76\u4e0d\u662f\u5341\u5206\u4e50\u89c2\u3002\u6309\u7167SVB Securities\u5206\u6790\u5e08\u7684\u4f30\u7b97\uff0cZynteglo\u548cSkysona\u6bcf\u5e74\u7684\u9500\u552e\u989d\u6700\u7ec8\u5c06\u8fbe\u52301.00\u4ebf\u7f8e\u5143\uff0c\u8fd9\u5e76\u4e0d\u8db3\u4ee5\u5e2e\u52a9Bluebird\u7684\u81ea\u7531\u73b0\u91d1\u6d41\u8f6c\u6b63\u3002\u4e0d\u8fc7\uff0c\u8fd9\u5bb6\u751f\u7269\u79d1\u6280\u516c\u53f8\u7684\u9570\u72b6\u7ec6\u80de\u75c5\uff08SCD\uff09\u57fa\u56e0\u7597\u6cd5lovo-cel\u6709\u53ef\u80fd\u5e26\u6765\u98a0\u8986\u6027\u7684\u5f71\u54cd\u3002<\/p>\n<h2>lovo-cel\u7684\u5e02\u573a\u6f5c\u529b<\/h2>\n<p>\u7f8e\u56fd\u94f6\u884c\u8bc1\u5238\u5206\u6790\u5e08Jason Gerberry\u6700\u8fd1\u5c06Bluebird\u7684\u80a1\u7968\u8bc4\u7ea7\u4e0a\u8c03\u81f3\u201c\u4e70\u5165\u201d\uff0c\u76ee\u6807\u80a1\u4ef7\u4e0a\u8c03\u81f310\u7f8e\u5143\uff0c\u76f8\u6bd4\u8be5\u80a1\u76ee\u524d\u4ef7\u683c\u4e0a\u6da8\u6f5c\u529b\u9ad8\u8fbe163%\u3002\u8fd9\u4e00\u8bc4\u7ea7\u8c03\u5347\u7684\u6838\u5fc3\u7406\u7531\u5728\u4e8elovo-cel\u76ee\u6807\u5e02\u573a\u5185\u5728\u7684\u5546\u4e1a\u673a\u4f1a\u3002\u6309\u7167Bluebird\u7684\u5185\u90e8\u4f30\u7b97\u2014\u2014\u7f8e\u56fd2\u4e07\u540d\u9570\u72b6\u7ec6\u80de\u75c5\u60a3\u8005\uff0c\u6bcf\u60a3\u8005\u8d85\u8fc7200\u4e07\u7f8e\u5143\u7684\u5b9a\u4ef7\uff0c\u4ee5\u53ca20%\u7684\u6e17\u900f\u7387\u2014\u2014lovo-cel\u7684\u5e74\u9500\u552e\u989d\u6709\u671b\u8fbe\u523080\u4ebf\u7f8e\u5143\u3002<\/p>\n<p>\u4f46\u4e8b\u5b9e\u4e0a\uff0c80\u4ebf\u7f8e\u5143\u7684\u5e74\u5cf0\u503c\u9500\u552e\u989d\u6781\u6709\u53ef\u80fd\u4f1a\u662f\u4e00\u4e2a\u9065\u4e0d\u53ef\u53ca\u7684\u76ee\u6807\u3002\u7a76\u5176\u539f\u56e0\uff0c\u76ee\u524d\u7684\u9570\u72b6\u7ec6\u80de\u75c5\u6cbb\u7597\u5e02\u573a\u7531\u5c0f\u5206\u5b50\u836f\u7269\u4e3b\u5bfc\uff0c\u672a\u6765\u8fd8\u5c06\u9762\u4e34\u5176\u4ed6\u57fa\u56e0\u7f16\u8f91\u7597\u6cd5\u7684\u7ade\u4e89\u3002\u5c3d\u7ba1\u5982\u6b64\uff0c\u5728\u8fd9\u4e2a\u7f55\u89c1\u75c5\u9886\u57df\uff0clovo-cel\u6210\u4e3a\u91cd\u78c5\u836f\uff08\u5e74\u9500\u552e\u989d\u8d85\u8fc710\u4ebf\u7f8e\u5143\uff09\u5e94\u8be5\u95ee\u9898\u4e0d\u5927\u3002\u5bf9\u4e8e\u4e00\u5bb6\u5e02\u503c\u53ea\u67094.05\u4ebf\u7f8e\u5143\u7684\u751f\u7269\u5236\u836f\u516c\u53f8\u6765\u8bf4\uff0c\u8fd9\u4e00\u4f30\u7b97\u6536\u5165\u5df2\u7ecf\u662f\u76f8\u5f53\u53ef\u89c2\u4e86\u3002<\/p>\n<p>\u56e0\u6b64\uff0c\u5982\u679cFDA\u572812\u670820\u65e5\u76ee\u6807\u5ba1\u67e5\u65e5\u671f\u4e4b\u524d\u6279\u51c6lovo-cel\uff0cBluebird\u7684\u80a1\u4ef7\u5e94\u8be5\u4f1a\u76f4\u7ebf\u98d9\u5347\u3002\u800c\u4e00\u65e6\u62ff\u4e0b\u9570\u72b6\u7ec6\u80de\u75c5\u7684\u57fa\u56e0\u7597\u6cd5\uff0c\u8fd9\u53ea\u751f\u7269\u79d1\u6280\u80a1\u5c06\u6210\u4e3a2024\u5e74\u521d\u6700\u91cd\u8981\u7684\u6536\u8d2d\u76ee\u6807\u3002\u65e0\u8bba\u662f\u4ece\u6536\u8d2d\u6240\u9700\u7684\u8d22\u52a1\u8d44\u6e90\u8fd8\u662f\u4ea7\u54c1\u7ec4\u5408\u7684\u89d2\u5ea6\u5206\u6790\uff0c\u5b89\u8fdbAmgen\uff08NASDAQ:AMGN\uff09\u3001\u518d\u751f\u5143\u5236\u836fRegeneron Pharmaceuticals\uff08NASDAQ:REGN\uff09\uff0c\u4ee5\u53ca\u6e24\u5065Biogen\uff08NASDAQ:BIIB\uff09\u90fd\u6709\u53ef\u80fd\u662f\u6f5c\u5728\u7684\u6c42\u8d2d\u8005\u3002<\/p>\n<h2>\u53ef\u80fd\u7684\u98ce\u9669<\/h2>\n<p>\u91cd\u5927\u7684\u76d1\u7ba1\u51b3\u5b9a\u51fa\u7089\u524d\uff0cBluebird\u7684\u80a1\u4ef7\u4e3a\u4f55\u4e0d\u52304\u7f8e\u5143\uff1f\u5173\u952e\u7684\u539f\u56e0\u5728\u4e8e\u8be5\u516c\u53f8\u7684\u8d22\u52a1\u72b6\u51b5\u3002\u6700\u8fd1\u5b63\u5ea6\u672b\uff0cBluebird\u7684\u73b0\u91d1\u3001\u73b0\u91d1\u7b49\u4ef7\u7269\u3001\u9650\u5236\u7528\u9014\u7684\u73b0\u91d1\u548c\u77ed\u671f\u8bc1\u5238\u7684\u603b\u989d\u4e3a2.91\u4ebf\u7f8e\u5143\u3002\u6309\u7167\u8be5\u516c\u53f8\u7684\u4f30\u7b97\uff0c\u8fd9\u4e9b\u8d44\u91d1\u5c06\u8db3\u4ee5\u8986\u76d6\u622a\u81f32024\u5e74\u4e8c\u5b63\u5ea6\u7684\u8425\u4e1a\u8d39\u7528\u3002\u5982\u679c\u660e\u5e74\u521d\u8fd8\u6ca1\u6709\u5176\u4ed6\u516c\u53f8\u6765\u6536\u8d2d\uff0cBluebird\u5c06\u4e0d\u5f97\u4e0d\u901a\u8fc7\u516c\u5f00\u53d1\u884c\u8fdb\u884c\u878d\u8d44\uff0c\u8fd9\u65e0\u7591\u4f1a\u7ed9\u8be5\u80a1\u80a1\u4ef7\u65bd\u538b\u5de8\u5927\u7684\u538b\u529b\u3002<\/p>\n<h2>\u73b0\u5728\u662f\u4e70\u5165\u65f6\u673a\u5417\uff1f<\/h2>\n<p>Bluebird\u7684\u77ed\u671f\u524d\u666f\u53d6\u51b3\u4e8elovo-cel\u83b7\u6279\u540e\u8be5\u516c\u53f8\u80fd\u5426\u5438\u5f15\u5230\u4e70\u5bb6\u3002\u8003\u8651\u4e86lovo-cel\u7684\u5e02\u573a\u524d\u666f\u4ee5\u53ca\u8be5\u80a1\u76ee\u524d\u7684\u4f4e\u4f30\u503c\uff0c\u88ab\u6536\u8d2d\u7684\u8bbe\u60f3\u5e76\u975e\u4e0d\u5207\u5b9e\u9645\u3002\u6b64\u5916\uff0c\u8be5\u516c\u53f8\u53ef\u80fd\u6ca1\u6709\u8db3\u591f\u7684\u8d44\u6e90\u5b9e\u73b0lovo-cel\u7684\u81ea\u4e3b\u4e0a\u5e02\uff0c\u800c\u589e\u53d1\u80a1\u7968\u6709\u53ef\u80fd\u5bfc\u81f4\u80a1\u4ef7\u8dcc\u7834\u7eb3\u65af\u8fbe\u514b\u7684\u4e0a\u5e02\u6700\u4f4e\u6807\u51c6\uff0c\u8fdb\u800c\u4e0d\u5f97\u4e0d\u91c7\u53d6\u53cd\u5411\u62c6\u80a1\uff08\u5e76\u80a1\uff09\u7684\u63aa\u65bd\u3002<\/p>\n<p>\u7ba1\u7406\u5c42\u5f53\u7136\u4e0d\u5e0c\u671b\u51fa\u73b0\u8fd9\u79cd\u7ed3\u679c\uff0c\u4f46\u6536\u8d2d\u4e5f\u4e0d\u662f\u5fc5\u7136\u7684\u7ed3\u679c\u3002\u5bf9\u4e8e\u9570\u72b6\u7ec6\u80de\u75c5\u57fa\u56e0\u7597\u6cd5\u7684\u957f\u671f\u76c8\u5229\u80fd\u529b\uff0c\u6216\u8005\u6216\u662f\u672a\u6765\u51e0\u5e74\u8fd9\u4e2a\u9886\u57df\u7684\u7ade\u4e89\u72b6\u51b5\uff0c\u5927\u578b\u5236\u836f\u5546\u7684\u5fc3\u91cc\u53ef\u80fd\u4e5f\u6ca1\u5e95\u3002\u8fd9\u4e2a\u6545\u4e8b\u8fd8\u6709\u5f88\u591a\u7684\u4e0d\u786e\u5b9a\u6027\uff0c\u56e0\u6b64\u6295\u8d44\u8005\u8981\u6709\u98ce\u9669\u610f\u8bc6\uff0c\u5ba1\u6279\u7ed3\u679c\u51fa\u7089\u524d\u4e0d\u5b9c\u5927\u89c4\u6a21\u5efa\u4ed3\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>FDA\u7684\u5ba1\u6279\u51b3\u5b9a\u6216\u6210\u4e3a\u8fd9\u53ea\u751f\u7269\u79d1\u6280\u516c\u53f8\u751f\u547d\u5468\u671f\u7684\u4e00\u4e2a\u62d0\u70b9 \u5bf9\u4e8e\u6210\u957f\u6295\u8d44\u8005\u6765\u8bf4\uff0c\u57fa\u56e0\u7597\u6cd5\u9f99\u5934\u516c\u53f8Bluebird [&hellip;]<\/p>\n","protected":false},"author":27,"featured_media":469050,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[1521,430],"tags":[455,747,766,925],"class_list":["post-470862","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-1521","category-trends-strategies-zh-hans","tag-455","tag-747","tag-766","tag-925","sectors-life-science-zh-hans","locations-us-zh-hans","exchange-nasdaq-zh-hans"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/470862","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/users\/27"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/comments?post=470862"}],"version-history":[{"count":0,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/470862\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media\/469050"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media?parent=470862"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/categories?post=470862"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/tags?post=470862"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}